400 related articles for article (PubMed ID: 24389329)
1. Targeting the nucleolus for cancer intervention.
Quin JE; Devlin JR; Cameron D; Hannan KM; Pearson RB; Hannan RD
Biochim Biophys Acta; 2014 Jun; 1842(6):802-16. PubMed ID: 24389329
[TBL] [Abstract][Full Text] [Related]
2. The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapy.
Woods SJ; Hannan KM; Pearson RB; Hannan RD
Biochim Biophys Acta; 2015 Jul; 1849(7):821-9. PubMed ID: 25464032
[TBL] [Abstract][Full Text] [Related]
3. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
Calo E; Gu B; Bowen ME; Aryan F; Zalc A; Liang J; Flynn RA; Swigut T; Chang HY; Attardi LD; Wysocka J
Nature; 2018 Feb; 554(7690):112-117. PubMed ID: 29364875
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RNA polymerase I transcription initiation by CX-5461 activates non-canonical ATM/ATR signaling.
Quin J; Chan KT; Devlin JR; Cameron DP; Diesch J; Cullinane C; Ahern J; Khot A; Hein N; George AJ; Hannan KM; Poortinga G; Sheppard KE; Khanna KK; Johnstone RW; Drygin D; McArthur GA; Pearson RB; Sanij E; Hannan RD
Oncotarget; 2016 Aug; 7(31):49800-49818. PubMed ID: 27391441
[TBL] [Abstract][Full Text] [Related]
5. The nucleolus: an emerging target for cancer therapy.
Hein N; Hannan KM; George AJ; Sanij E; Hannan RD
Trends Mol Med; 2013 Nov; 19(11):643-54. PubMed ID: 23953479
[TBL] [Abstract][Full Text] [Related]
6. Targeting RNA polymerase I transcription and the nucleolus for cancer therapy.
Hannan RD; Drygin D; Pearson RB
Expert Opin Ther Targets; 2013 Aug; 17(8):873-8. PubMed ID: 23862680
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar residence of the seckel syndrome protein TRAIP is coupled to ribosomal DNA transcription.
Chen Y; Li J; Cao F; Lam J; Cheng CC; Yu CH; Huen MS
Nucleic Acids Res; 2018 Nov; 46(19):10119-10131. PubMed ID: 30165463
[TBL] [Abstract][Full Text] [Related]
8. The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.
Dong Z; Zhu C; Zhan Q; Jiang W
Oncotarget; 2017 Feb; 8(8):13240-13252. PubMed ID: 28099941
[TBL] [Abstract][Full Text] [Related]
9. p53 induces a survival transcriptional response after nucleolar stress.
Liao H; Gaur A; Mauvais C; Denicourt C
Mol Biol Cell; 2021 Oct; 32(20):ar3. PubMed ID: 34319761
[TBL] [Abstract][Full Text] [Related]
10. Functional ribosome biogenesis is a prerequisite for p53 destabilization: impact of chemotherapy on nucleolar functions and RNA metabolism.
Burger K; Eick D
Biol Chem; 2013 Sep; 394(9):1133-43. PubMed ID: 23640940
[TBL] [Abstract][Full Text] [Related]
11. Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription.
Li Z; Hann SR
Oncogene; 2013 Apr; 32(15):1988-94. PubMed ID: 22665062
[TBL] [Abstract][Full Text] [Related]
12. The nucleolus: Coordinating stress response and genomic stability.
González-Arzola K
Biochim Biophys Acta Gene Regul Mech; 2024 Jun; 1867(2):195029. PubMed ID: 38642633
[TBL] [Abstract][Full Text] [Related]
13. Distinct states of nucleolar stress induced by anticancer drugs.
Potapova TA; Unruh JR; Conkright-Fincham J; Banks CAS; Florens L; Schneider DA; Gerton JL
Elife; 2023 Dec; 12():. PubMed ID: 38099650
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
Bywater MJ; Poortinga G; Sanij E; Hein N; Peck A; Cullinane C; Wall M; Cluse L; Drygin D; Anderes K; Huser N; Proffitt C; Bliesath J; Haddach M; Schwaebe MK; Ryckman DM; Rice WG; Schmitt C; Lowe SW; Johnstone RW; Pearson RB; McArthur GA; Hannan RD
Cancer Cell; 2012 Jul; 22(1):51-65. PubMed ID: 22789538
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the nucleolus and cancer: Current evidence and emerging paradigms.
Orsolic I; Jurada D; Pullen N; Oren M; Eliopoulos AG; Volarevic S
Semin Cancer Biol; 2016 Jun; 37-38():36-50. PubMed ID: 26721423
[TBL] [Abstract][Full Text] [Related]
16. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.
Lee HC; Wang H; Baladandayuthapani V; Lin H; He J; Jones RJ; Kuiatse I; Gu D; Wang Z; Ma W; Lim J; O'Brien S; Keats J; Yang J; Davis RE; Orlowski RZ
Br J Haematol; 2017 Apr; 177(1):80-94. PubMed ID: 28369725
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer.
Bursać S; Prodan Y; Pullen N; Bartek J; Volarević S
Trends Cancer; 2021 Jan; 7(1):57-76. PubMed ID: 32948502
[TBL] [Abstract][Full Text] [Related]
18. Targeting the nucleolus for cancer-specific activation of p53.
Drygin D; O'Brien SE; Hannan RD; McArthur GA; Von Hoff DD
Drug Discov Today; 2014 Mar; 19(3):259-65. PubMed ID: 23993916
[TBL] [Abstract][Full Text] [Related]
19. The nucleolus, an ally, and an enemy of cancer cells.
Stępiński D
Histochem Cell Biol; 2018 Dec; 150(6):607-629. PubMed ID: 30105457
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar RNA polymerase II drives ribosome biogenesis.
Abraham KJ; Khosraviani N; Chan JNY; Gorthi A; Samman A; Zhao DY; Wang M; Bokros M; Vidya E; Ostrowski LA; Oshidari R; Pietrobon V; Patel PS; Algouneh A; Singhania R; Liu Y; Yerlici VT; De Carvalho DD; Ohh M; Dickson BC; Hakem R; Greenblatt JF; Lee S; Bishop AJR; Mekhail K
Nature; 2020 Sep; 585(7824):298-302. PubMed ID: 32669707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
